|
MyoGene Bio LLC |
Courtney Young |
Therapeutic Translational Research Projects |
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy |
$3,400,000 |
|
University of California, San Francisco |
Arun Wiita |
Therapeutic Translational Research Projects |
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia |
$3,330,801 |
|
University of California, Irvine |
Aileen Anderson |
Therapeutic Translational Research Projects |
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury |
$4,950,024 |
|
Organos Inc. |
Samuel Wall |
Tool Translational Research Projects |
Human iPSC-derived micro-heart muscles for high-throughput cardiac drug discovery |
$1,119,382 |
|
University of California, Irvine |
Olga Razorenova |
Conference II |
UCI Stem Cell Research Center 9th Annual Stem Cell Science Symposium |
$8,366 |
|
Biomedical Engineering Society |
Ryan Green |
Conference II |
2022 BMES-CMBE Annual Meeting: "Lighting and Leading the Way: Molecular Tools in Multicellular Systems” |
$15,000 |
|
University of Southern California |
Frank Petrigliano |
Late Stage Preclinical Projects |
Plurocart: a novel stem cell-based implant for articular cartilage restoration |
$5,999,782 |
|
Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center |
Virender Rehan |
Research Training Grant |
Stem Cell Training Program at the Lundquist Institute |
$4,975,367 |
|
The Regents of the University of California on behalf of its Riverside Campus |
Prudence Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$4,993,115 |
|
University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,000,000 |
|
University of Southern California |
Gage DeKoeyer Crump |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,000,000 |
|
University of California, Santa Cruz |
Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$4,913,271 |
|
Gladstone Institutes, J. David |
Bruce Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,000,000 |
|
City of Hope, Beckman Research Institute |
Michael Barish |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$4,860,989 |
|
Stanford University |
Tushar Desai |
Research Training Grant |
CIRM Scholar Training Program |
$4,974,073 |
|
University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$4,954,238 |
|
University of California, Davis |
Jan Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$4,966,300 |
|
Children's Hospital of Los Angeles |
Ching-Ling Lien |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$4,999,500 |
|
University of California, San Diego |
Alysson Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$4,992,446 |
|
Scripps Research Institute |
Peter Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$4,931,353 |
|
University of California, San Francisco |
Robert Blelloch |
Research Training Grant |
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research |
$5,000,000 |
|
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Research Training Grant |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$4,915,671 |
|
University of California, Santa Barbara |
Dennis Clegg |
Research Training Grant |
CIRM Training Program in Stem Cell Biology and Engineering |
$1,924,497 |
|
Stanford University |
Matthew Porteus |
Clinical Trial Stage Projects |
Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. |
$10,563,822 |
|
University of California, Irvine |
Peter Donovan |
Research Training Grant |
CIRM Scholars Comprehensive Research Training Program |
$5,000,000 |
|
Cedars-Sinai Medical Center |
Wafa Tawackoli |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$4,999,333 |
|
Stanford University |
Gary Steinberg |
Clinical Trial Stage Projects |
Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke |
$11,998,988 |
|
Stanford University |
Crystal Mackall |
Clinical Trial Stage Projects |
Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma |
$11,998,310 |
|
Stanford University |
Joseph Wu |
Clinical Trial Stage Projects |
A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR) |
$6,987,507 |
|
University of California, Davis |
Deborah Lieu |
Quest - Discovery Stage Research Projects |
Building a hiPSC-based biopacemaker |
$1,260,827 |
|
University of California, San Diego |
Tannishtha Reya |
Quest - Discovery Stage Research Projects |
Targeting Critical Regulators of Cancer Stem Cells |
$1,148,264 |
|
University of California, San Francisco |
Marisa Medina |
Quest - Discovery Stage Research Projects |
iPSCs as a screening tool to predict risk of nonalcoholic fatty liver disease |
$813,000 |
|
University of California, Irvine |
Munjal Acharya |
Quest - Discovery Stage Research Projects |
Stem cell-derived extracellular vesicles to reverse radiation-induced brain injury |
$1,064,724 |
|
Stanford University |
Kathleen Sakamoto |
Quest - Discovery Stage Research Projects |
Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia |
$848,098 |
|
Stanford University |
Phillip Yang |
Quest - Discovery Stage Research Projects |
Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair |
$1,418,023 |
|
University of California, Davis |
David Segal |
Quest - Discovery Stage Research Projects |
AAV9-Cas13 gene therapy for Angelman syndrome |
$1,364,903 |
|
Stanford University |
Marius Wernig |
Quest - Discovery Stage Research Projects |
A universally applicable skin sheet for Dystrophic Epidermolysis Bullosa via next-generation gene editing, iPS cell technology and tissue engineering |
$1,229,040 |
|
University of California, San Diego |
Dan Kaufman |
Quest - Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor expressing macrophages for improved cancer treatment. |
$1,256,332 |
|
University of California, San Diego |
Ziwei Huang |
Quest - Discovery Stage Research Projects |
Development of a new therapeutic for directing target specific stem cell migration and treatment |
$1,129,512 |
|
Stanford University |
Stanley Qi |
Quest - Discovery Stage Research Projects |
A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering |
$704,661 |
|
Cal State Univ, Fullerton |
Nilay Patel |
Bridges |
Bridges to Stem Cell Research and Therapy: A Talent Development Program for Training Diverse Undergraduates for Careers in Regenerative Medicine |
$3,606,500 |
|
Berkeley City College |
Barbara Des Rochers |
Bridges |
CIRM Bridges to Stem Cell Research and Therapy |
$2,793,870 |
|
Pasadena City College |
Pamela Eversole-Cire |
Bridges |
Bridges to Stem Cell Research and Therapy at Pasadena City College |
$3,313,385 |
|
California State University San Marcos Corporation |
Bianca Mothe |
Bridges |
CIRM Bridges to Stem Cell Research and Therapy Training Grant |
$3,606,500 |
|
San Diego State University Foundation |
Ralph Feuer |
Bridges |
Bridges to Stem Cell Research Internship Program |
$3,542,376 |
|
Humboldt State University Sponsored Programs Foundation |
Amy Sprowles |
Bridges |
CIRM Bridges 3.0 |
$3,605,495 |
|
Cal State Univ, Long Beach |
Lisa Klig |
Bridges |
CIRM Regenerative Medicine and Stem Cell Research Biotechnology Training Program |
$3,268,765 |
|
SJSU Research Foundation |
Bree Grillo - Hill |
Bridges |
Stem Cell Internships in Laboratory-based Learning ( SCILL) continue to expand the scientific workforce for stem cells research and therapies . |
$3,606,500 |
|
Cal State Univ, Sacramento |
Kimberly Mulligan |
Bridges |
Strengthening the Pipeline of Master's-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,946,500 |
|
San Francisco State University |
Lily Chen |
Bridges |
CIRM Bridges Science Master’s Program |
$3,606,500 |
|
California State University, Channel Islands |
Nitika Parmar |
Bridges |
CIRM Graduate Student Training in Stem Cell Sciences in the Stem Cell Technology and Lab Management Emphasis of the MS Biotechnology Program |
$3,558,692 |
|
The University Corporation at California State University, Northridge |
Cindy Malone |
Bridges |
CSUN CIRM Bridges3.0 Stem Cell Research & Therapy Training Program |
$3,606,500 |
|
Cal State Univ, San Bernadino |
Nicole Bournias-Vardiabasis |
Bridges |
Stem Cell Scholars: a workforce development pipeline, educating, training and engaging students from basic research to clinical translation. |
$3,606,500 |
|
University of California, San Francisco |
Mark Walters |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |
|
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo |
Trevor Cardinal |
Bridges |
Training Masters Students to Advance the Regenerative Medicine Field |
$3,276,500 |
|
City College Of San Francisco |
Carin Zimmerman |
Bridges |
Building Career Pathways into Stem Cell Research and Therapy Development |
$2,706,200 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
Clinical Trial Stage Projects |
CNS10-NPC-GDNF delivered into the motor cortex for the treatment of ALS |
$11,990,372 |
|
University of California, San Francisco |
Hideho Okada |
Therapeutic Translational Research Projects |
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma |
$525,000 |
|
University of California, Los Angeles |
Lili Yang |
Therapeutic Translational Research Projects |
HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma |
$5,281,199 |
|
University of California, Los Angeles |
Cristina Puig Saus |
Therapeutic Translational Research Projects |
CAR-Tnm cell therapy for melanoma targeting TYRP-1 |
$5,904,462 |
|
Immune-Onc Therapeutics |
Joseph Woodard |
Clinical Trial Stage Projects |
Phase 1 Clinical Development of IO-202, A First-in-Class Antibody Targeting LILRB4, for the Treatment of AML with Monocytic Differentiation and CMML |
$6,000,000 |
|
City of Hope, Beckman Research Institute |
Leo Wang |
Clinical Trial Stage Projects |
Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors |
$8,401,309 |
|
University of California, Irvine |
Mathew Blurton-Jones |
Quest - Discovery Stage Research Projects |
Transplantation of Pluripotent Stem Cell Derived Microglia for the Treatment of Adult-onset Leukoencephalopathy (HDLS/ALSP) |
$214,668 |
|
University of Southern California |
Justin Ichida |
Quest - Discovery Stage Research Projects |
Development of a SYF2 antisense oligonucleotide (ASO) treatment for ALS |
$222,300 |
|
University of California, Irvine |
Robert Hunt |
Quest - Discovery Stage Research Projects |
Optimization of a human interneuron cell therapy for traumatic brain injury |
$250,000 |
|
University of California, Los Angeles |
Stanley Carmichael |
Quest - Discovery Stage Research Projects |
Human-induced pluripotent stem cell-derived glial enriched progenitors to treat white matter stroke and vascular dementia. |
$250,000 |
|
University of California, San Diego |
Tariq Rana |
Quest - Discovery Stage Research Projects |
Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids |
$250,000 |
|
City of Hope, Beckman Research Institute |
Yanhong Shi |
Quest - Discovery Stage Research Projects |
Combating COVID-19 using human PSC-derived NK cells |
$249,998 |
|
Boston Children's Hospital |
David Williams |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease |
$8,333,581 |
|
University of California, San Francisco |
Steven Deeks |
Clinical Trial Stage Projects |
Anti-HIV duoCAR-T cell therapy for HIV infection |
$8,970,732 |
|
Rocket Pharmaceuticals, Inc. |
Gayatri Rao |
Clinical Trial Stage Projects |
A Phase I Clinical Trial for a Lentiviral Gene Therapy Targeting the TCIRG1 Gene for Infantile Malignant Osteopetrosis (IMO) |
$1,010,000 |
|
University of California, Davis |
Diana Farmer |
Clinical Trial Stage Projects |
The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair |
$8,996,474 |
|
University of California, San Diego |
Dan Kaufman |
Quest - Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor-expressing macrophages for cancer treatment |
$222,200 |
|
University of California, Los Angeles |
Donald Kohn |
Quest - Discovery Stage Research Projects |
Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia |
$219,230 |
|
Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center |
Eiji Yoshihara |
Quest - Discovery Stage Research Projects |
Dual angiogenic and immunomodulating nanotechnology for subcutaneous stem cell derived islet transplantation for the treatment of diabetes |
$250,000 |
|
Vitabolus, Inc. |
Aline Betancourt |
Quest - Discovery Stage Research Projects |
The First Orally Delivered Cell Therapy for the Treatment of Inflammatory Bowel Disease |
$249,000 |
|
University of California, San Diego |
John Brock |
Progression Award - Discovery Stage Research Projects |
Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury |
$180,000 |
|
Stanford University |
Helen Blau |
Progression Award - Discovery Stage Research Projects |
Stimulating endogenous muscle stem cells to counter muscle wasting |
$237,060 |
|
University of California, Berkeley |
Kevin Healy |
Progression Award - Discovery Stage Research Projects |
Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy |
$224,500 |
|
University of California, Irvine |
Brian Cummings |
Progression Award - Discovery Stage Research Projects |
Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) |
$202,667 |
|
University of California, San Diego |
Karen Christman |
Discovery Research Projects |
Pro-healing biomaterial for treating lung inflammation associated with COVID-19 |
$221,758 |
|
University of California, Los Angeles |
Lili Yang |
Discovery Research Projects |
Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
|
Neurona Therapeutics |
Cory Nicholas |
Progression Award - Discovery Stage Research Projects |
Global gene expression profiling of single inhibitory neurons derived from human stem cells |
$202,500 |
|
University of California, Irvine |
Daniela Bota |
Conference – The 2020 Grantee Meeting |
2020 CIRM Grantee Meeting |
$176,762 |
|
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Discovery Research Projects |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$228,229 |
|
University of California, San Diego |
Steve Dowdy |
Discovery Research Projects |
Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells |
$150,000 |
|
Celularity Inc. |
William van der Touw |
Clinical Trial Stage Projects |
A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 |
$315,000 |
|
University of Southern California |
PREET Chaudhary |
Discovery Research Projects |
Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2 |
$248,125 |
|
University of California, Los Angeles |
Song Li |
Discovery Research Projects |
Biomaterial vaccine to enhance the formation of SARS-CoV-2-specific T memory stem cells |
$149,916 |
|
University of California, Los Angeles |
Vaithilingaraja Arumugaswami |
Therapeutic Translational Research Projects |
COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage |
$349,999 |
|
Stanford University |
Helen Blau |
Discovery Research Projects |
Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy |
$149,996 |
|
Stanford University |
Albert Wong |
Discovery Research Projects |
Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 |
$249,999 |
|
City of Hope, Beckman Research Institute |
Jianhua Yu |
Discovery Research Projects |
Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19 |
$150,000 |
|
University of California, Los Angeles |
Caroline Kuo |
Progression Award - Discovery Stage Research Projects |
Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 |
$234,000 |
|
Scripps Research Institute |
Stuart Lipton |
Discovery Research Projects |
Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage |
$150,000 |
|
University of Southern California |
Justin Ichida |
Discovery Research Projects |
Development of a novel PIKFYVE kinase inhibitor for the treatment of COVID-19 |
$140,067 |
|
University of California, San Francisco |
Michael Matthay |
Clinical Trial Stage Projects |
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative) |
$701,049 |
|
ExCellThera Inc. |
Pierre Caudrelier |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease. |
$600,000 |
|
University of California, Los Angeles |
Brigitte Gomperts |
Discovery Research Projects |
Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids |
$149,998 |
|
University of California, Los Angeles |
Gay Crooks |
Discovery Research Projects |
Stem cell-based rapid identification of SARS-CoV-2 T cell epitopes and T cell receptors for therapeutic use |
$126,692 |
